BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36866236)

  • 1. The Comprehensive Analysis of N6-Methyadenosine Writer METTL3 and METTL14 in Gastric Cancer.
    Ge Y; Zhang Y; Yang S; Liu T; Zhang T; Feng Y; Wang C; Liang G
    J Oncol; 2023; 2023():9822995. PubMed ID: 36866236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of METTL3 and METTL14 in hepatocellular carcinoma.
    Liu X; Qin J; Gao T; Li C; Chen X; Zeng K; Xu M; He B; Pan B; Xu X; Pan Y; Sun H; Xu T; Wang S
    Aging (Albany NY); 2020 Nov; 12(21):21638-21659. PubMed ID: 33159022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of methyltransferase-like enzyme 3 and methyltransferase-like enzyme 14 in urological cancers.
    Tao Z; Zhao Y; Chen X
    PeerJ; 2020; 8():e9589. PubMed ID: 32765970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL14 is a chromatin regulator independent of its RNA N6-methyladenosine methyltransferase activity.
    Dou X; Huang L; Xiao Y; Liu C; Li Y; Zhang X; Yu L; Zhao R; Yang L; Chen C; Yu X; Gao B; Qi M; Gao Y; Shen B; Sun S; He C; Liu J
    Protein Cell; 2023 Sep; 14(9):683-697. PubMed ID: 37030005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative proteomics and m6A microarray analyses of the signatures induced by METTL3 reveals prognostically significant in gastric cancer by affecting cellular metabolism.
    Peng G; Chen S; Zheng N; Tang Y; Su X; Wang J; Dong R; Wu D; Hu M; Zhao Y; Liu M; Wu H
    Front Oncol; 2022; 12():996329. PubMed ID: 36465351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3-METTL14 complex induces necroptosis and inflammation of vascular smooth muscle cells via promoting N6 methyladenosine mRNA methylation of receptor-interacting protein 3 in abdominal aortic aneurysms.
    Li K; Zhang D; Zhai S; Wu H; Liu H
    J Cell Commun Signal; 2023 Sep; 17(3):897-914. PubMed ID: 36947363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The m
    Sang L; Wu X; Yan T; Naren D; Liu X; Zheng X; Zhang N; Wang H; Li Y; Gong Y
    J Cancer; 2022; 13(3):1019-1030. PubMed ID: 35154467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3 and METTL14 regulate IL-6 expression via RNA m6A modification of zinc transporter SLC39A9 and DNA methylation of IL-6 in periodontal ligament cells.
    Huang J; Wang Y; Zhou Y
    Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119605. PubMed ID: 37821055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
    J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway.
    Yang DD; Chen ZH; Yu K; Lu JH; Wu QN; Wang Y; Ju HQ; Xu RH; Liu ZX; Zeng ZL
    Front Oncol; 2020; 10():115. PubMed ID: 32175271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition of G-quadruplex RNA by a crucial RNA methyltransferase component, METTL14.
    Yoshida A; Oyoshi T; Suda A; Futaki S; Imanishi M
    Nucleic Acids Res; 2022 Jan; 50(1):449-457. PubMed ID: 34908152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-methyladenosine methyltransferase plays a role in hypoxic preconditioning partially through the interaction with lncRNA H19.
    Su Y; Xu R; Zhang R; Qu Y; Zuo W; Ji Z; Geng H; Pan M; Ma G
    Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(12):1306-1315. PubMed ID: 33197240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of N6-adenosine-methyltransferase subunits METTL3 and METTL14 in the biological properties of periodontal ligament cells.
    Huang J; Guo C; Wang Y; Zhou Y
    Tissue Cell; 2023 Jun; 82():102081. PubMed ID: 37018927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into roles of METTL14 in tumors.
    Liu X; Du Y; Huang Z; Qin H; Chen J; Zhao Y
    Cell Prolif; 2022 Jan; 55(1):e13168. PubMed ID: 34904301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of N6-Methyladenosine Methyltransferase Reveals METTL14 and ZC3H13 as Tumor Suppressor Genes in Breast Cancer.
    Gong PJ; Shao YC; Yang Y; Song WJ; He X; Zeng YF; Huang SR; Wei L; Zhang JW
    Front Oncol; 2020; 10():578963. PubMed ID: 33363011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.
    Liu X; Xiao M; Zhang L; Li L; Zhu G; Shen E; Lv M; Lu X; Sun Z
    J Clin Lab Anal; 2021 Mar; 35(3):e23655. PubMed ID: 33314339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL14 inhibits the malignant processes of gastric cancer cells by promoting N6-methyladenosine (m6A) methylation of TAF10.
    Zhao X; Lu J; Wu W; Li J
    Heliyon; 2024 Jun; 10(11):e32014. PubMed ID: 38882361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation.
    Yuan Y; Du Y; Wang L; Liu X
    J Cancer; 2020; 11(12):3588-3595. PubMed ID: 32284755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.